Product information and disease descriptionProduct descriptionProduct information
Generic, brand name and therapeutic class of product
5 evidence topics · 6 sources
Generic name, chemical name, and identifiers
| Field | Quoted record |
|---|---|
| International nonproprietary name (Latin) | “lanifibranorum” |
| International nonproprietary name (English) | “lanifibranor” |
| Chemical name | “4-[1-(1,3-benzothiazole-6-sulfonyl)-5-chloro-1H-indol- 2-yl]butanoic acid” |
| Functional description | “peroxisome proliferator-activated receptors (PPAR) agonist” |
| Molecular formula | “C19H15ClN2O4S2” |
| CAS registry number | “927961-18-0” |
| INN list | “Proposed INN: List 116” |
Development code: IVA337
| Field | Quoted record |
|---|---|
| Arm | “Lanifibranor (IVA 337) (800 mg/day)” |
| Arm | “Lanifibranor (IVA 337) (1200 mg/day)” |
Brand name
No evidence found.